Early research (Phase 1)Study completedNCT00003761What this trial is testingVaccine Therapy in Treating Patients With Metastatic Breast CancerWho this might be right forBreast Cancer Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT02067741What this trial is testingCR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast CancerWho this might be right forMetastatic Breast AdenocarcinomaBreast Cancer Swiss Cancer Institute 29
Not applicableStudy completedNCT01624220What this trial is testingA Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation TherapyWho this might be right forSpinal Tumor M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Looking for participantsNCT06265025What this trial is testingGM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsWho this might be right forHead and Neck CancerMalignant MelanomaColorectal Cancer+3 more GeneMedicine Co., Ltd. 125
Large-scale testing (Phase 3)Ended earlyNCT04588246What this trial is testingComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more NRG Oncology 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613What this trial is testingCediranib in Combination With Olaparib in Advanced Solid TumorsWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more National Cancer Institute (NCI) 122
Early research (Phase 1)Looking for participantsNCT06270706What this trial is testingPLN-101095 in Adults With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumor Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)Study completedNCT01693549What this trial is testingStudy of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With TaxanesWho this might be right forBreast Cancer Hellenic Cooperative Oncology Group 84
Testing effectiveness (Phase 2)Ended earlyNCT03875313What this trial is testingStudy of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid TumorsWho this might be right forSolid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more Calithera Biosciences, Inc 33
Not applicableStudy completedNCT01598597What this trial is testingAn Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)Who this might be right forBreast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more Genentech, Inc. 276
Testing effectiveness (Phase 2)UnknownNCT03544723What this trial is testingSafety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.Who this might be right forSolid TumorLymphoma MultiVir, Inc. 40
Early research (Phase 1)Ended earlyNCT02543645What this trial is testingVarlilumab and Atezolizumab in Patients With Advanced CancerWho this might be right forCarcinoma, Renal CellKidney DiseasesKidney Neoplasms+11 more Celldex Therapeutics 18
Early research (Phase 1)Looking for participantsNCT07369505What this trial is testingSapu003 in Advanced mTOR-sensitive Solid TumorsWho this might be right forBreast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more SAPU NANO (US) LLC 27
Testing effectiveness (Phase 2)Looking for participantsNCT05732831What this trial is testingSafety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsWho this might be right forLocally Advanced Solid Tumor Tango Therapeutics, Inc. 225
Early research (Phase 1)Study completedNCT04750473What this trial is testingFluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Invasive Breast Lobular CarcinomaMetastatic Breast Lobular Carcinoma+1 more Emory University 20
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT01407770What this trial is testingGenetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast CancerWho this might be right forBreast CancerCognitive Ability, GeneralFatigue+4 more Wake Forest University Health Sciences 1,000
Testing effectiveness (Phase 2)Ended earlyNCT05714553What this trial is testingNUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursWho this might be right forAdvanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more NuCana plc 19
Testing effectiveness (Phase 2)Ended earlyNCT04260802What this trial is testingEvaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersWho this might be right forCancerNeoplasmsMetastatic Cancer+16 more Ocellaris Pharma, Inc. 73
Large-scale testing (Phase 3)Temporarily pausedNCT02037529What this trial is testingEribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast CancerWho this might be right forBreast AdenocarcinomaHER2/Neu NegativeInvasive Breast Carcinoma+2 more Academic and Community Cancer Research United 201